What is Lenire?
Lenire is first and only dual mode technology for the treatment of tinnitus granted US FDA approval. Large scale clinical trial results show the device to be a safe and effective tinnitus treatment. 4
What is Tinnitus?
Tinnitus affects up to 15% of people and can be experienced as a ringing or buzzing in the ears. A person with tinnitus hears noise when there is no external source.
Resources and Success Stories
Learn how it works and how our three large-scale clinical trials were designed.
Watch this video to hear patient success stories from our clinical trials.
Learn how you can manage tinnitus and find more resources on the blog.
1. TENT-A1 Conlon et al., Sci. Transl. Med. 12, eabb2830 (2020)
2. TENT-A2: Conlon et al., Different bimodal neuromodulation settings reduce tinnitus symptoms in a large randomized trial, Sci Rep.
3. TENT-A3: Clinical trial data in preparation for independent publication: clinicaltrials.gov/ct2/show/NCT05227365.
4. Aggregate: TENT-A1, TENT-A2, TENT-A3 aggregate clinical trial results.
Note 1: All statistics based on compliant patients. Patient compliance criteria is detailed in Lenire’s clinical trial design.
Note 2: TENT-A1/TENT-A2 were not considered by the United States of America FDA as part of Lenire’s FDA Grant and, as such, applies solely to outside the US.